Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.89
+0.07 (1.03%)
Apr 8, 2026, 1:31 PM EDT - Market open

Ginkgo Bioworks Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4014595043,3823,19713,391
Market Cap Growth
1.47%-9.05%-85.09%5.78%-76.12%-
Enterprise Value
417.73453.23381.612,6602,29511,925
Last Close Price
6.898.319.8267.6067.60332.40
PE Ratio
--1.47-0.93-3.68-1.35-5.98
PS Ratio
2.352.702.2213.456.6942.67
PB Ratio
0.780.900.703.081.848.90
P/TBV Ratio
0.750.910.713.001.647.51
P/FCF Ratio
--2.57-1.32-10.06-10.50-43.15
P/OCF Ratio
--2.68-1.58-11.45-12.68-52.76
EV/Sales Ratio
2.462.661.6810.584.8038.00
EV/EBITDA Ratio
--1.77-0.77-3.35-1.06-6.63
EV/EBIT Ratio
--1.44-0.68-3.08-1.04-6.52
EV/FCF Ratio
--2.54-1.00-7.91-7.54-38.43
Debt / Equity Ratio
0.820.820.610.200.240.01
Debt / EBITDA Ratio
-1.63-1.63-0.88-0.28-0.19-0.01
Debt / FCF Ratio
-2.33-2.33-1.15-0.66-1.36-0.07
Net Debt / Equity Ratio
-0.01-0.01-0.17-0.66-0.52-1.01
Net Debt / EBITDA Ratio
0.020.020.250.910.420.85
Net Debt / FCF Ratio
0.030.030.322.152.964.92
Asset Turnover
0.140.140.150.120.210.23
Inventory Turnover
----121.4842.54
Quick Ratio
4.664.665.445.878.0812.51
Current Ratio
4.924.925.626.118.3812.79
Return on Equity (ROE)
-51.08%-51.08%-60.34%-63.02%-127.52%-180.29%
Return on Assets (ROA)
-25.18%-25.18%-36.76%-41.11%-95.15%-133.06%
Return on Invested Capital (ROIC)
-46.36%-46.36%-83.58%-101.67%-289.00%-545.84%
Return on Capital Employed (ROCE)
-27.49%-27.49%-40.39%-44.70%-102.68%-144.08%
Earnings Yield
-78.10%-67.87%-107.33%-27.17%-73.96%-16.73%
FCF Yield
-44.63%-38.96%-75.76%-9.94%-9.52%-2.32%
Buyback Yield / Dilution
-6.87%-6.87%-6.76%-15.75%-23.48%-6.72%
Total Shareholder Return
-6.87%-6.87%-6.76%-15.75%-23.48%-6.72%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q